摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1,1'-(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(2-methylpropan-1-one) | 1146624-30-7

中文名称
——
中文别名
——
英文名称
1,1'-(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(2-methylpropan-1-one)
英文别名
2-Methyl-1-[2,3,5-trihydroxy-7-methyl-6-[1,6,7-trihydroxy-3-methyl-5-(2-methylpropanoyl)naphthalen-2-yl]naphthalen-1-yl]propan-1-one
1,1'-(1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-2,2'-binaphthyl-5,5'-diyl)bis(2-methylpropan-1-one)化学式
CAS
1146624-30-7
化学式
C30H30O8
mdl
——
分子量
518.563
InChiKey
LPPABNKXPGAEFO-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.2
  • 重原子数:
    38
  • 可旋转键数:
    5
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.27
  • 拓扑面积:
    156
  • 氢给体数:
    6
  • 氢受体数:
    8

文献信息

  • NAPHTHALENE-BASED INHIBITORS OF ANTI-APOPTOTIC PROTEINS
    申请人:Pellecchia Maurizio
    公开号:US20090105319A1
    公开(公告)日:2009-04-23
    Methods of using apogossypol and its derivatives for treating inflammation is disclosed. Also, there is described a group of compounds having structure A, or a pharmaceutically acceptable salt, hydrate, N-oxide, or solvate thereof are provided: wherein each R is independently selected from the group consisting of H, C(O)X, C(O)NHX, NH(CO)X, SO 2 NHX, and NHSO 2 X, wherein X is selected from the group consisting of an alkyl, a substituted alkyl, an aryl, a substituted aryl, an alkylaryl, and a heterocycle. Compounds of group A may be used for treating various diseases or disorders, such as cancer.
    使用阿波戈司宝及其衍生物治疗炎症的方法被披露。此外,还描述了一组具有结构A的化合物,或其药学上可接受的盐、合物、N-氧化物或溶剂化合物: 其中每个R独立地选自H、C(O)X、C(O)NHX、NH(CO)X、SO2NHX和NHSO2X组成的组,其中X选自烷基、取代烷基、芳基、取代芳基、烷基芳基和杂环的组。A组化合物可用于治疗各种疾病或疾病,如癌症。
  • Napthalene-Based Inhibitors of Anti-Apoptotic Proteins
    申请人:Pellecchia Maurizio
    公开号:US20120015992A1
    公开(公告)日:2012-01-19
    Methods of using apogossypol and its derivatives for treating inflammation is disclosed. Also, there is described a group of compounds having structure A, or a pharmaceutically acceptable salt, hydrate, N-oxide, or solvate thereof are provided: wherein each R is independently H, C(O)X, C(O)NHX, NH(CO)X, SO 2 NHX, or NHSO 2 X, wherein X is hydrogen, alkyl, substituted alkyl, aryl, substituted aryl, alkylaryl, substituted alkylaryl, heterocycle, or substituted heterocycle. Compounds of group A may be used for treating various diseases or disorders, such as cancer.
    本文披露了使用阿泊果及其衍生物治疗炎症的方法。此外,还提供了一组具有结构A的化合物,或其药学上可接受的盐、合物、N-氧化物或溶剂化物:其中每个R独立地为H、C(O)X、C(O)NHX、NH(CO)X、SO2NHX或NHSO2X,其中X为氢、烷基、取代烷基、芳基、取代芳基、烷基芳基、取代烷基芳基、杂环或取代杂环。A组化合物可用于治疗各种疾病或疾病,如癌症。
  • Chemical entities that kill senescent cells for use in treating age-related disease
    申请人:Unity Biotechnology, Inc.
    公开号:US10195213B2
    公开(公告)日:2019-02-05
    Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
    本文公开的化合物可有效治疗与衰老有关的各种疾病状态。所公开的化合物可用于消除衰老细胞以治疗疾病。化合物的给药方式包括单次给药和循环给药。
  • COMPOUNDS AND THERAPEUTIC USES
    申请人:Unity Biotechnology, Inc.
    公开号:US20170281649A1
    公开(公告)日:2017-10-05
    Disclosed herein are compounds that are effective for treatment of various disease states associated with senescence. The disclosed compounds can be used to eliminate senescent cells for disease treatment. The dosing of the compounds includes both single administration and regimens of cycling dosages.
  • US8039668B2
    申请人:——
    公开号:US8039668B2
    公开(公告)日:2011-10-18
查看更多